115 related articles for article (PubMed ID: 3038598)
1. Retinoic acid-induced differentiation of the human promyelocytic leukemia cell line, HL-60, and fresh human leukemia cells in primary culture: a model for differentiation inducing therapy of leukemia.
Imaizumi M; Breitman TR
Eur J Haematol; 1987 Apr; 38(4):289-302. PubMed ID: 3038598
[No Abstract] [Full Text] [Related]
2. Appearance of the arachidonic acid metabolic pathway in human promyelocytic leukemia (HL-60) cells during monocytic differentiation: enhancement of thromboxane synthesis by 1 alpha,25-dihydroxyvitamin D-3.
Honda A; Morita I; Murota S; Mori Y
Biochim Biophys Acta; 1986 Jul; 877(3):423-32. PubMed ID: 3089289
[TBL] [Abstract][Full Text] [Related]
3. A T lymphocyte-derived differentiation-inducing factor for myeloid leukemia cells: purification and characterization.
Olsson I; Gullberg U; Sarngadharan MG; Gallo RC
Haematol Blood Transfus; 1985; 29():423-5. PubMed ID: 3875528
[No Abstract] [Full Text] [Related]
4. The role of 13 cis-retinoic acid in the remission induction of a patient with acute promyelocytic leukemia.
Fontana JA; Rogers JS; Durham JP
Cancer; 1986 Jan; 57(2):209-17. PubMed ID: 3455835
[TBL] [Abstract][Full Text] [Related]
5. Study of differentiation of fresh myeloid leukemic cells by physiologic agents that induce a human promyelocytic leukemic line (HL-60) to differentiate.
Chaplinski TJ; Bennett TE
Leuk Res; 1986; 10(6):611-7. PubMed ID: 3012213
[TBL] [Abstract][Full Text] [Related]
6. A combination of a T cell-derived lymphokine differentiation-inducing activity and a physiologic concentration of retinoic acid induces HL-60 to differentiate to cells with functional chemotactic peptide receptors.
Imaizumi M; Breitman TR
Blood; 1986 May; 67(5):1273-80. PubMed ID: 3008888
[TBL] [Abstract][Full Text] [Related]
7. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid.
Breitman TR; Collins SJ; Keene BR
Blood; 1981 Jun; 57(6):1000-4. PubMed ID: 6939451
[TBL] [Abstract][Full Text] [Related]
8. Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL-60.
Honma Y; Fujita Y; Kasukabe T; Hozumi M; Sampi K; Sakurai M; Tsushima S; Nomura H
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):251-61. PubMed ID: 6572149
[TBL] [Abstract][Full Text] [Related]
9. Induction by physiological agents of differentiation of the human leukemia cell line HL-60 to cells with functional characteristics.
Breitman TR; Hemmi H; Imaizumi M
Prog Clin Biol Res; 1986; 226():215-33. PubMed ID: 3543956
[No Abstract] [Full Text] [Related]
10. New facts and speculations on human myeloid leukemias.
Breitman TR; Gallo RC
Blood Cells; 1981; 7(1):79-89. PubMed ID: 6964818
[TBL] [Abstract][Full Text] [Related]
11. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
Miyaura C; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlation between induction of chemotactic peptide receptors and stimulus-induced actin polymerization in HL-60 cells treated with dibutyryl cyclic adenosine monophosphate or retinoic acid.
Rao KM; Currie MS; Ruff JC; Cohen HJ
Cancer Res; 1988 Dec; 48(23):6721-6. PubMed ID: 2846157
[TBL] [Abstract][Full Text] [Related]
13. Distinct differentiation-inducing activities of gamma-interferon and cytokine factors acting on the human promyelocytic leukemia cell line HL-60.
Harris PE; Ralph P; Gabrilove J; Welte K; Karmali R; Moore MA
Cancer Res; 1985 Jul; 45(7):3090-5. PubMed ID: 2988760
[TBL] [Abstract][Full Text] [Related]
14. Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3':5'-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor.
Olsson IL; Breitman TR; Gallo RC
Cancer Res; 1982 Oct; 42(10):3928-33. PubMed ID: 6286101
[TBL] [Abstract][Full Text] [Related]
15. Differentiating agents in the treatment of leukemia.
Degos L
Leuk Res; 1990; 14(8):717-9. PubMed ID: 2201823
[TBL] [Abstract][Full Text] [Related]
16. Effects of retinoic acid on the fibrinolytic activity of HL 60 human promyelocytic leukemia cells.
Ghezzo F; Pegoraro L
Experientia; 1981 Apr; 37(4):425-6. PubMed ID: 6940759
[No Abstract] [Full Text] [Related]
17. [Proliferation and differentiation of cells and differentiation- inducing treatment in leukemia].
Kuliczkowski K
Pol Arch Med Wewn; 1992 Jul; 88(1):49-56. PubMed ID: 1454660
[No Abstract] [Full Text] [Related]
18. Potential applications of cytodifferentiation therapy in hematologic malignancies.
Breitman TR; Chen ZX; Takahashi N
Semin Hematol; 1994 Oct; 31(4 Suppl 5):18-25. PubMed ID: 7831581
[TBL] [Abstract][Full Text] [Related]
19. Identification of a regulatory peptide distinct from normal granulocyte-derived hemoregulatory peptide produced by human promyelocytic HL-60 leukemia cells after differentiation induction with retinoic acid.
Paukovits JB; Paukovits WR; Laerum OD
Cancer Res; 1986 Sep; 46(9):4444-8. PubMed ID: 3460696
[TBL] [Abstract][Full Text] [Related]
20. Lipids of human promyelocytic leukemia cell HL-60: increasing levels of ether-linked phospholipids during retinoic acid-induced differentiation.
Naito M; Kudo I; Nakagawa Y; Waku K; Nojiri H; Saito M; Inoue K
J Biochem; 1987 Jul; 102(1):155-62. PubMed ID: 3478334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
